---
title: "Closing Review: The three major indices rebounded strongly, and the cross-border payment concept surged in the afternoon"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242333158.md"
description: "The three major indices rebounded strongly, with the ChiNext Index and Shenzhen Component Index closing up over 1%. The cross-border payment concept surged in the afternoon, with Lakala, Forms Syntron, and TANSUN hitting the daily limit; the innovative drug concept rose, with ChemPartner, Staidson BioPharm, and InventisBio also hitting the daily limit; the autonomous driving concept remained strong, with Sanyou Technology hitting the daily limit. The consumer sector adjusted, with the beauty and personal care segment leading the decline. The Shanghai Composite Index closed at 3363.45 points, up 0.70%; the Shenzhen Component Index closed at 10127.20 points, up 1.24%; the ChiNext Index closed at 2012.55 points, up 1.37%"
datetime: "2025-05-29T07:02:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242333158.md)
  - [en](https://longbridge.com/en/news/242333158.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242333158.md)
generator: "portal-rs"
---

# Closing Review: The three major indices rebounded strongly, and the cross-border payment concept surged in the afternoon

The three major indices rebounded strongly, with the ChiNext Index and the Shenzhen Component Index closing up over 1%. In terms of sectors, the cross-border payment concept surged in the afternoon, with Lakala, Forms Syntron, and TANSUN hitting the 20% daily limit; the innovative drug concept rose, with ChemPartner, Staidson BioPharm, and InventisBio all hitting the daily limit during trading; the autonomous driving concept continued to be strong, with Sanyou Technology hitting the 30% daily limit, and WanMa Technology and YuHeTian both hitting the 20% daily limit; the consumer sector collectively adjusted, with the beauty and personal care segment leading the decline, and Lafang Household Products seeing significant losses; food and beverage stocks fell into a correction, with JinFeng Wine Industry and Jiaoda Onlly leading the decline; the gold concept declined, with LaiShen TongLing hitting the daily limit. Overall, individual stocks showed a general upward trend, with over 4,300 stocks rising. By the close, the Shanghai Composite Index was at 3,363.45 points, up 0.70%; the Shenzhen Component Index was at 10,127.20 points, up 1.24%; and the ChiNext Index was at 2,012.55 points, up 1.37%. On the market, the electronic ID, cross-border payment, and data rights confirmation sectors had the largest gains, while precious metals, glyphosate, and beauty and personal care sectors had the largest declines

### Related Stocks

- [300872.CN](https://longbridge.com/en/quote/300872.CN.md)
- [300204.CN](https://longbridge.com/en/quote/300204.CN.md)
- [688382.CN](https://longbridge.com/en/quote/688382.CN.md)
- [300149.CN](https://longbridge.com/en/quote/300149.CN.md)
- [300468.CN](https://longbridge.com/en/quote/300468.CN.md)
- [300773.CN](https://longbridge.com/en/quote/300773.CN.md)
- [603630.CN](https://longbridge.com/en/quote/603630.CN.md)
- [603900.CN](https://longbridge.com/en/quote/603900.CN.md)
- [600616.CN](https://longbridge.com/en/quote/600616.CN.md)
- [300698.CN](https://longbridge.com/en/quote/300698.CN.md)
- [600530.CN](https://longbridge.com/en/quote/600530.CN.md)
- [300815.CN](https://longbridge.com/en/quote/300815.CN.md)

## Related News & Research

- [Subscribe for Symbiotec Pharmalab Ltd IPO; Ajcon Global](https://longbridge.com/en/news/296742246.md)
- [Across the country, Kennedy touts MAHA, but not vaccines](https://longbridge.com/en/news/296685679.md)
- [SP Group corrects disclosure, names Schur Finance as buyer of 31,500 shares at DKK 485](https://longbridge.com/en/news/296803384.md)
- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [YMTC's STAR Mkt IPO Application Accepted, w/ Plans to Raise RMB33B](https://longbridge.com/en/news/296724109.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**